COMMUNIQUÉS West-GlobeNewswire

Vaccinex Presents Updated Interim Results from a Phase 1b/2 Study of Pepinemab in Combination with Avelumab in Non-Small Cell Lung Cancer at the 2019 ASCO Annual Meeting
03/06/2019
ROCHESTER, N.Y., June 03, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today [...]
Agios Presents Updated Data from Phase 1 Studies of TIBSOVO® (ivosidenib) in Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy
03/06/2019
– With Longer Follow Up, CR+CRh Rate Increased to 70% and CR Rate Increased to 61% in the Phase 1 Study of TIBSOVO ® in Combination with Azacitidine – – Phase 1 Data of Single Agent TIBSOVO ® Demonstrated 12.6 Month [...]
Progenics Pharmaceuticals Mails Letter to Shareholders
03/06/2019
Asks Shareholders to Vote “FOR” All the Company’s Qualified Directors on the WHITE Proxy Card NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) (“Progenics” or the “Company”), an [...]
Neon Therapeutics to Present at Jefferies 2019 Healthcare Conference
03/06/2019
CAMBRIDGE, Mass., June 03, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that Hugh O’Dowd, Chief [...]
Immutep Presentation at ASCO 2019
03/06/2019
SYDNEY, Australia, June 03, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Humanigen to Present at the Jefferies 2019 Healthcare Conference
03/06/2019
BURLINGAME, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Humanigen, Inc., (HGEN) (“Humanigen”) a biopharmaceutical company focused on the development of its proprietary Humaneered ® monoclonal antibodies focused on [...]
AIT Therapeutics to Participate at Jefferies 2019 Global Healthcare Conference
03/06/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, June 03, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
Outlook Therapeutics Signs Manufacturing Supply Agreement with FUJIFILM Diosynth Biotechnologies as Part of Commercialization Strategy for ONS-5010
03/06/2019
CRANBURY, N.J., June 03, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”), a late clinical-stage biopharmaceutical company focused on developing ONS-5010, a proprietary ophthalmic [...]
Todos Medical Announces Positive Clinical Trial Data for Breast Cancer Blood Test TM-B1 in Dense Breasts
03/06/2019
TM-B1 demonstrates 80% accuracy vs. 50% accuracy for current gold standard Todos Medical to attend 2019 ASCO Annual Meeting in Chicago, IL REHOVOT, Israel, June 03, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: [...]
BioSig Technologies Receives $4.6 Million in Cash Warrant and Option Exercises
03/06/2019
Santa Monica, CA, June 03, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Annual General Meeting Results and Statement
03/06/2019
Acacia Pharma Group plc Annual General Meeting Results and Statement Cambridge, UK and Indianapolis, US – 3 June 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH) announces that all [...]
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness
03/06/2019
GAITHERSBURG, Md., June 03, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract award by the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. [...]
LHC Group announces finalization of purchase agreement and joint venture partnership in New Jersey
03/06/2019
LAFAYETTE, La., June 03, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) and AtlantiCare – A Member of Geisinger have finalized a previously announced joint venture (JV) agreement and purchase that includes home [...]
RadNet, Inc. to Present at the Jefferies 2019 Healthcare Conference on June 7, 2019
03/06/2019
LOS ANGELES, June 03, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
US FDA Review for SCENESSE® Extended by Three Months
03/06/2019
The FDA sets new goal date of 6 October 2019 to complete review and issue risk-benefit decision MELBOURNE, Australia, June 03, 2019 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today published that the US Food and [...]
Arrayit Corporation Signs In-Network Allergy Testing Services Agreement with a Major California-Based Health Benefits Company
03/06/2019
Sunnyvale, June 03, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, has entered into an in-network healthcare provider agreement with a major health benefits [...]
Biohit Plc - Managers' transactions - Söderström
03/06/2019
Person subject to the notification requirement Name: Söderström, Daniela Position: Other senior manager Issuer: Biohit Plc LEI: 74370089ATTSNBXJVT29 Notification type: INITIAL NOTIFICATION Reference number: [...]
Icosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expression Technology
03/06/2019
Tartu (Estonia) and Plzen (Czech Republic) June 3, 2019 - Icosagen Cell Factory OÜ, a rapidly growing Estonian biotechnology company focusing on protein production and in vivo antibody discovery, and AbCheck s.r.o., a [...]
Oncology Venture receives response from the FDA to the IND-application and proposed pivotal study for LiPlaCis
03/06/2019
Press release Hoersholm, Denmark and Cambridge, MA, US, June 3, 2019. – Oncology Venture A/S (“OV” or “the Company”) today announced that the FDA has given its initial response to the Company’s IND application and [...]

Pages